Nanotechnology Systems in Drug Delivery to the Anterior Segment of the Eye—A Narrative Review of the Latest Preclinical Research Results
Preprint
- 31 March 2026
- preprint
- Published by MDPI AG in Preprints.org
Abstract
Background: Eye diseases represent a significant public health problem. The effectiveness of ophthalmic pharmacotherapy largely depends on efficient drug delivery to the eye tissues. Conventional eye drops exhibit low bioavailability due to anatomical and physiological barriers. Nanotechnology offers novel strategies to enhance drug penetration, retention, and controlled release within the anterior segment of the eye. This study aimed to systematically analyze preclinical research on the use of nanocarriers in drug delivery to the anterior segment. Methods: A literature review was conducted using PubMed, Scopus, and Google Scholar databases, covering English-language publications from 2019 to 2025. Preclinical studies evaluating nanocarriers for the treatment of anterior segment eye diseases and available in full text were included. Results: The analyzed studies indicate that nanocarriers, including solid lipid nanoparticles, nanostructured lipid carriers, nanomicelles, and polymeric nanoparticles, enhance drug bioavailability by improving mucoadhesion, facilitating penetration through the corneal epithelium, and prolonging ocular surface retention time. Key physicochemical parameters include small particle size, low polydispersity index, appropriate zeta potential, and high encapsulation efficiency. Preclinical models demonstrated improved therapeutic outcomes, including greater intraocular pressure reduction in glaucoma, increased tear production in dry eye syndrome, and enhanced anti-inflammatory and antifungal effects compared with conventional preparations. Conclusions: Nanotechnology-based drug delivery systems represent a promising strategy for improving therapy of the anterior segment eye diseases. However, further preclinical and clinical studies are required to confirm their clinical applicability.Keywords
All Related Versions
This publication has 54 references indexed in Scilit:
- Self-assembled nanoparticles in ocular delivery: a comprehensive reviewDiscover Applied Sciences, 2025
- Impact of major age-related eye disorders on health-related quality of life assessed by EQ-5D: a systematic review and meta-analysisGraefe's Archive for Clinical and Experimental Ophthalmology, 2023
- Polymer- and lipid-based nanocarriers for ocular drug delivery: Current status and future perspectivesAdvanced Drug Delivery Reviews, 2023
- Dry eye syndrome: comprehensive etiologies and recent clinical trialsInternational Ophthalmology, 2022
- A Hydrogel Ionic Circuit Based High‐Intensity Iontophoresis Device for Intraocular Macromolecule and Nanoparticle DeliveryAdvanced Materials, 2021
- The Emerging Role of Topical Ocular Drugs to Target the Posterior EyeOphthalmology and Therapy, 2021
- A Global Assessment of Eye Health and Quality of LifeJAMA Ophthalmology, 2021
- Strategies to prolong the residence time of drug delivery systems on ocular surfaceAdvances in Colloid and Interface Science, 2021
- Dually functional hollow ceria nanoparticle platform for intraocular drug delivery: A push beyond the limits of static and dynamic ocular barriers toward glaucoma therapyBiomaterials, 2020
- Preclinical testing—Understanding the basics first2020